Uchida, T., Kaira, K., Yamaguchi, O., Mouri, A., Shiono, A., Miura, Y., . . . Kagamu, H. (2019). Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer. Wiley.
Chicago Style (17th ed.) CitationUchida, Takahiro, et al. Different Incidence of Interstitial Lung Disease According to Different Kinds of EGFR‐tyrosine Kinase Inhibitors Administered Immediately Before And/or After Anti‐PD‐1 Antibodies in Lung Cancer. Wiley, 2019.
MLA (9th ed.) CitationUchida, Takahiro, et al. Different Incidence of Interstitial Lung Disease According to Different Kinds of EGFR‐tyrosine Kinase Inhibitors Administered Immediately Before And/or After Anti‐PD‐1 Antibodies in Lung Cancer. Wiley, 2019.